Publication Date:
1981-04-17
Description:
An investigation of the efficacy of astatine-211--tellurium colloid for the treatment of experimental malignant ascites in mice reveals that this alpha-emitting radiocolloid can be curative without causing undue toxicity to normal tissue. By comparison, negatron-emitting phosphorus-32 as colloidal chromic phosphate had no antineoplastic activity. The most compelling explanation for this striking difference is the dense ionization and short range of action associated with alpha-emission. These results have important implications for the development and use of alpha-emitters as radiocolloid therapy for the treatment of human tumors.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Bloomer, W D -- McLaughlin, W H -- Neirinckx, R D -- Adelstein, S J -- Gordon, P R -- Ruth, T J -- Wolf, A P -- CA-12662/CA/NCI NIH HHS/ -- CA-15523/CA/NCI NIH HHS/ -- NS-15380/NS/NINDS NIH HHS/ -- New York, N.Y. -- Science. 1981 Apr 17;212(4492):340-1.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/7209534" target="_blank"〉PubMed〈/a〉
Keywords:
Alpha Particles
;
Animals
;
Ascites/*radiotherapy
;
Astatine/*therapeutic use
;
Cell Survival/radiation effects
;
Chromium/therapeutic use
;
*Chromium Compounds
;
Colloids
;
Female
;
Mice
;
Neoplasm Transplantation
;
Neoplasms, Experimental/*radiotherapy
;
Ovarian Neoplasms
;
Phosphates/therapeutic use
;
Phosphorus Radioisotopes/therapeutic use
;
Radioisotopes/*therapeutic use
;
Tellurium/*therapeutic use
;
Transplantation, Homologous
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink